Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $405.4100 (-0.39%) ($402.8200 - $409.6800) on Wed. Mar. 20, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.99% (three month average) | RSI | 37 | Latest Price | $405.4100(-0.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | Weekly Trend | REGN declines -2.8% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(59%) XLV(48%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.995% in a week (0% probabilities). UUP(-11%) VXX(-10%) TLT(-6%) IFRA(-6%) XHB(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.995% (StdDev 1.99%) | Hourly BBV | 0 () | Intraday Trend | -0.6% | | | |
|
Resistance Level | $418.47 | 5 Day Moving Average | $408.39(-0.73%) | 10 Day Moving Average | $409.24(-0.94%) | 20 Day Moving Average | $418.47(-3.12%) | To recent high | -7.8% | To recent low | 19% | Market Cap | $42.985b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |